Standout Papers

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diab... 2008 2026 2014 2020 1.8k
  1. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes (2013)
    William B. White, Christopher P. Cannon et al. New England Journal of Medicine
  2. Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial (2015)
    Faı̈ez Zannad, Christopher P. Cannon et al. The Lancet
  3. Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes (2008)
    Steven E. Nissen, Stephen J. Nicholls et al. JAMA

Immediate Impact

1 by Nobel laureates 5 from Science/Nature 92 standout
Sub-graph 1 of 14

Citing Papers

Treatment of Hypertension
2022 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
16 intermediate papers

Works of Stuart Kupfer being referenced

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
2015 Standout
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
2013 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Stuart Kupfer 2259 3867 325 1618 78 5.5k
K. Bridget Brosnihan 3480 3127 258 1188 89 7.3k
Christian G. Brilla 5688 2613 269 1504 63 7.6k
Eberhard Standl 1995 5815 170 2049 205 8.8k
Gérald Luc 2947 2544 338 1763 87 8.9k
Mary J. Malloy 1640 1875 638 1620 133 7.0k
Melvin R. Hayden 1707 1860 390 1341 142 6.0k
Frederik Persson 2281 3217 202 1196 180 6.0k
Rhonda M. Cooper‐DeHoff 3963 1851 553 933 192 6.9k
Viviane Nicaud 1934 1666 189 1292 112 5.7k
Raymond P. Bain 3184 2967 325 920 57 8.6k

All Works

Loading papers...

Rankless by CCL
2026